glp level 1 GLP-1 for Weight Loss and Diabetes The Latest on GLP-1s |

However, adverse events, particularly nausea and digestive symptoms, were more common among participants taking GLP-1 drugs, and some stopped treatment due to side effects

The Food and Drug Administration issued a warning letter to Novo Nordisk the maker of Ozempic and Wegovy for failing to report potential side effects in patients who took its blockbuster medications

But and this is critical thats just a hope

After a couple months youll keep the weight off for good

3 Among firms with 5,000 or more workers, coverage had increased to 43% up from 28% the year prior but many of those employers reported that utilization was higher than expected and that covering the medications had a significant impact on 3 Several firms that initially offered coverage had since restricted it to employees with specific medical indications, such as type 2 diabetes, with some noting the challenge of removing a benefit that employees had come to rely on

Wear time: Follow brand instructions